Pharmaceutical Technology sat down with Mattia Wiedemeier, Sales Manager of Engineering at Lonza to discuss the benefits of micronization and the advantages of microdosing in early-phase drug development.
* The presented information was correct and current at the time of publication.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center